Will Endometrial Cancer treatment make me infertile

Endometrial Cancer Treatment and Fertility: What You Need to Know

This is an important question, and the answer depends significantly on what type of treatment you receive and your specific cancer characteristics. Let me explain what the evidence shows.

Standard Treatment and Fertility

The typical treatment for endometrial cancer is a total hysterectomy (removal of the uterus) with bilateral salpingo-oophorectomy (BSO—removal of both fallopian tubes and ovaries). This procedure will make you unable to become pregnant naturally, since the uterus is removed.

However, according to NCCN Guidelines for Endometrial Carcinoma, there is an important exception for select patients.

Fertility-Sparing Options (For Specific Patients)

If you meet ALL of these strict criteria, fertility-preserving treatment may be considered:

✓ Grade 1 endometrioid adenocarcinoma (the most common, least aggressive type)
✓ Stage IA disease (cancer limited to the inner lining of the uterus)
✓ No evidence of spread to other areas
✓ Young age and strong desire to preserve fertility
✓ Ability to undergo close monitoring (biopsies every 3-6 months)
✓ Genetic counseling and evaluation for inherited cancer risk
✓ Consultation with a fertility specialist

How Fertility-Sparing Treatment Works

Instead of surgery, doctors may use continuous progestin-based therapy, which can include:

• Levonorgestrel IUD (intrauterine device)—preferred option
• Megestrol acetate (oral medication)
• Medroxyprogesterone acetate (oral medication)
• Dual-progestin therapy (combining two types)

According to NCCN Guidelines, about 50% of patients achieve complete response (cancer disappears) with this approach.

Important Reality Check

The NCCN Guidelines emphasize that fertility-sparing therapy is NOT standard care for endometrial cancer. Here's what you should know:

• Monitoring is intensive: You'll need endometrial biopsies or dilation and curettage (D&C) every 3-6 months
• Success rates have trade-offs: While some patients achieve complete response, studies show that 35% of patients who became pregnant after treatment still experienced cancer recurrence over long-term follow-up
• Time limits apply: If cancer persists after 6-12 months of progestin therapy, hysterectomy is typically recommended
• Pregnancy rates are modest: Only about 35% of young patients who had negative biopsies after hormonal therapy were able to become pregnant

What About Ovarian Preservation?

If you do have a hysterectomy, there's good news about your ovaries: According to NCCN Guidelines, ovarian preservation may be safe in select premenopausal patients with early-stage endometrioid cancer, particularly those without family history of ovarian cancer or Lynch syndrome.

This matters because:

• You can still produce eggs naturally
• You could potentially use egg freezing or embryo preservation before surgery if you want biological children
• You would avoid surgical menopause symptoms

Questions to Ask Your Oncology Team

Since fertility preservation is highly individualized, ask your doctor:

1. "Based on my specific cancer type, stage, and grade, am I a candidate for fertility-sparing treatment?"
2. "If I proceed with standard surgery, would ovarian preservation be appropriate for my case?"
3. "What are my options for egg or embryo freezing before treatment, and how quickly can this be arranged?"
4. "What is the realistic success rate for fertility-sparing therapy in my specific situation?"
5. "If I choose fertility-sparing treatment, what does the monitoring schedule look like, and what happens if cancer is still present after 6-12 months?"
6. "Should I consult with a fertility specialist before making my treatment decision?"

The Bottom Line

Standard endometrial cancer treatment will affect your ability to become pregnant naturally. However, if you have early-stage, low-grade disease and strongly desire fertility, fertility-sparing options exist—but they require careful patient selection, intensive monitoring, and realistic expectations about success rates.

The key is having this conversation early with your oncology team and a fertility specialist, so you understand all your options before treatment begins.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources: NCCN Guidelines for Endometrial Carcinoma (Version 1.2026)